Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Mar 26, 2022; 10(9): 2931-2937
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2931
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2931
Turner syndrome with primary myelofibrosis, cirrhosis and ovarian cystic mass: A case report
Lin-Wei Xu, Yong-Zhong Su, Hong-Fang Tao, Department of Hematology, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China
Author contributions: Xu LW was responsible for the clinical management of the patient and writing the paper; Tao HF treated the patient and revised the manuscript; Su YZ contributed to the follow-up of the patient; all authors contributed to the article and approved the submitted version.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hong-Fang Tao, PhD, Associate Chief Physician, Department of Hematology, The First Affiliated Hospital of Shantou University Medical College, No. 51 Changping Street, Shantou 515041, Guangdong Province, China. taohongfangchn@163.com
Received: October 8, 2021
Peer-review started: October 8, 2021
First decision: December 17, 2021
Revised: January 4, 2022
Accepted: February 12, 2022
Article in press: February 12, 2022
Published online: March 26, 2022
Processing time: 164 Days and 23.8 Hours
Peer-review started: October 8, 2021
First decision: December 17, 2021
Revised: January 4, 2022
Accepted: February 12, 2022
Article in press: February 12, 2022
Published online: March 26, 2022
Processing time: 164 Days and 23.8 Hours
Core Tip
Core Tip: A case of Turner syndrome (TS) with chronic myeloid proliferative neoplasm is very rare. Here we report a 20-year-old woman diagnosed with TS, primary myelofibrosis, cirrhosis, and an ovarian cystic mass. The level of myelofibrosis was reduced after ruxolitinib treatment, however, anemia, thrombocytopenia, cirrhosis and splenomegaly continued to worsen. This indicates that the deterioration of splenomegaly may be caused by portal hypertension. Other treatment options and special care for patients such as the one in this case should be discussed.